These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 660445)

  • 1. Bioequivalence and interchangeability.
    Hwang S; Huber PB; Hesney M; Kwan KC
    J Pharm Sci; 1978 Jun; 67(6):IV. PubMed ID: 660445
    [No Abstract]   [Full Text] [Related]  

  • 2. Individual bioequivalence. New concepts in the statistical assessment of bioequivalence metrics. FDA Individual Bioequivalence Working Group.
    Patnaik RN; Lesko LJ; Chen ML; Williams RL
    Clin Pharmacokinet; 1997 Jul; 33(1):1-6. PubMed ID: 9250419
    [No Abstract]   [Full Text] [Related]  

  • 3. Assessing bioequivalence and drug interchangeability.
    Chen M; Chow SC
    J Biopharm Stat; 2017; 27(2):272-281. PubMed ID: 27936343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Equivalence assessment for interchangeability based on two-sided tests.
    Dong X; Tsong Y
    J Biopharm Stat; 2014; 24(6):1312-31. PubMed ID: 25032976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Are therapeutic drugs freely interchangeable? Studies of bioavailability and bioequivalence].
    Blume H
    Verh Dtsch Ges Inn Med; 1988; 94():411-9. PubMed ID: 3061214
    [No Abstract]   [Full Text] [Related]  

  • 6. Bioequivalence assessment and the conduct of bioequivalence trials: a European point of view.
    Herchuelz A
    Eur J Drug Metab Pharmacokinet; 1996; 21(2):149-52. PubMed ID: 8839688
    [No Abstract]   [Full Text] [Related]  

  • 7. [Bioequivalence of generic drugs: sense and nonsense].
    Brune K; Dietzel K
    Fortschr Med; 1988 Nov; 106(33):16-7. PubMed ID: 3209169
    [No Abstract]   [Full Text] [Related]  

  • 8. Bioavailability and bioequivalence: average, population and/or individual.
    Colburn WA; Keefe DL
    J Clin Pharmacol; 2000 Jun; 40(6):559-60. PubMed ID: 10868304
    [No Abstract]   [Full Text] [Related]  

  • 9. Bioequivalence assessment: a pharmaceutical industry perspective.
    Godbillon J; Cardot JM; Lecaillon JB; Lefevre G; Sioufi A
    Eur J Drug Metab Pharmacokinet; 1996; 21(2):153-8. PubMed ID: 8839689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Assessment of bioequivalence].
    Aoyagi N
    Eisei Shikenjo Hokoku; 1996; (114):141-2. PubMed ID: 9037886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "One-size-fits-all" in bioavailability and bioequivalence testing?
    Blume HH
    Int J Clin Pharmacol Ther; 2009 Jul; 47(7):419-20. PubMed ID: 19640347
    [No Abstract]   [Full Text] [Related]  

  • 12. Generic drugs: bioequivalence and bioavailability.
    Ansbacher R
    JAMA; 1988 Jan; 259(2):220. PubMed ID: 2826829
    [No Abstract]   [Full Text] [Related]  

  • 13. Dilemma with matrix effect in bioanalysis--perspectives from bioavailability/bioequivalence studies for product registration?
    Srinivas NR
    Drug Res (Stuttg); 2014 Jun; 64(6):335-6. PubMed ID: 24258702
    [No Abstract]   [Full Text] [Related]  

  • 14. Society testifies on bioavailability, bioequivalence.
    Hayes AH
    Pa Med; 1975 Sep; 78(9):59-60. PubMed ID: 1178207
    [No Abstract]   [Full Text] [Related]  

  • 15. [3rd International Regulatory Workshop on A to Z on bioequivalence, bioanalysis, dissolution and biosimilarity].
    Acta Pharm Hung; 2012; 82(3):121-4. PubMed ID: 23230651
    [No Abstract]   [Full Text] [Related]  

  • 16. [Bioavailability of drug products and bioequivalence requirements (author's transl)].
    Jaminet F
    J Pharm Belg; 1978; 33(3):141-56. PubMed ID: 682101
    [No Abstract]   [Full Text] [Related]  

  • 17. [Bioequivalence of generic drugs].
    Schwabe U
    Internist (Berl); 1988 Mar; 29(3):147-59. PubMed ID: 3288573
    [No Abstract]   [Full Text] [Related]  

  • 18. Biometrical evaluation of bioequivalence trials using a bootstrap individual direct curve comparison method.
    Zintzaras E; Bouka P; Kowald A
    Eur J Drug Metab Pharmacokinet; 2002; 27(1):11-6. PubMed ID: 11996322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of bioequivalence trials. From analysis to statistic trials].
    Houin G
    Therapie; 1993; 48(4):289-95. PubMed ID: 8128417
    [No Abstract]   [Full Text] [Related]  

  • 20. Statistical aspects of bioequivalence testing between two medicinal products.
    Zintzaras E
    Eur J Drug Metab Pharmacokinet; 2005; 30(1-2):41-6. PubMed ID: 16010860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.